Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MF-101 reduces frequency and severity of postmenopausal hot flashes

June 6, 2007

Treatment completed in prophylactic phase III trial of C1-INH for HAE

June 6, 2007

AtheroGenics to focus on diabetes for AGI-1067

June 6, 2007

Takeda terminates development of fixed dose Actos + TAK-536 product

June 6, 2007

Transdermal low-dose contraceptive begins phase I pharmacokinetic program

June 5, 2007

Iroxanadine accelerates wound healing in diabetic animals

June 5, 2007

Orlistat GSK recommended for approval in E.U.

June 1, 2007

Novel agents for metabolic disorders described in recent patents

May 31, 2007

Recent patents describe new therapeutic agents for diabetes

May 30, 2007

Preclinical studies presented at ECTS

May 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...